Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-030743

Director acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thistle Mary Director 2021-03-04 Grant or award +5,000 5,000 D
Derivatives
Thistle Mary Director 2021-03-04 Grant or award · Stock Option (right to buy) +37,500 37,500 D
Thistle Mary Director 2021-03-04 Grant or award · Stock Option (right to buy) +150,000 150,000 D
Loading xslF345X03/doc4.xml…